The ViroKey™ SARS-CoV-2 RT-PCR Test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from individuals meeting CDC SARS-CoV-2 clinical criteria (e.g., clinical signs and symptoms associated with SARS-CoV-2 infection) in conjunction with CDC SARS-CoV-2 epidemiological criteria (e.g., history of residence in, or travel to a geographic region with active SARS-CoV-2 transmission at the time of travel, or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated).
The automated workflow is intended to be used on the Sentosa® SX101 with the Sentosa® SX Virus Total Nucleic Acid Kit v2.0 in conjunction with the Sentosa® SA201 instrument for high-throughput RT-PCR. The assay also fits into a manual workflow for laboratories with existing Applied Biosystems®7500 Fast Dx Real-Time PCR Instrument.
Positive results are indicative of active infection. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
For research use only. Not for use in diagnostic procedures.
Find out more here.
|Target Genes||Target Channel|
Providing Laboratory Efficiency:
Increasing Cost Effectiveness:
|Product||Pack Size||Item Number|
|Sentosa SX Virus Total Nucleic Acid Kit v2.0 (RUO)||4x24||300044|
|ViroKey SARS-CoV-2 RT-PCR Test (RUO)||4x48/ 4x50||300682|